常规CT提升结直肠癌检出率的策略
该回顾性研究纳入209例确诊前1年内因非结肠异常指征行CT的患者,由两名腹部放射科医师回顾性阅片。结果显示仅50.7%的肿瘤在原始报告中前瞻性检出,31.6%回顾性检出,17.7%未检出。未检出肿瘤平均更小(2.9 cm),右半结肠肿瘤更易被回顾性检出。建议无论CT指征如何均应仔细追踪结肠,右半结肠需额外关注,息肉样及不对称形态易被遗漏但可通过学习改善检出。
要点
- 仅半数结直肠肿瘤在原始CT报告中前瞻性检出,需提高警惕。
- 右半结肠肿瘤更易漏诊,回顾性检出率高于前瞻性。
- 息肉样及不对称肠壁增厚易被忽视,需针对性训练。
核心结论
- 所有结直肠肿瘤中仅一半被前瞻性检出,放射科医师应无论CT检查指征如何均仔细追踪结肠。
- 右半结肠需额外仔细检查,息肉样及不对称形态特征最常被忽视,但可通过学习提高检出。
研究设计与样本
- 回顾性研究,纳入209例确诊结直肠癌前1年内因非结肠异常指征行CT的患者。
- 由两名委员会认证的腹部亚专科放射科医师在知晓肿瘤位置和大小的情况下回顾病历和CT图像。
- 患者分为前瞻性检出组(106例,50.7%)、回顾性检出组(66例,31.6%)和未检出组(37例,17.7%)。
关键影像表现/征象
- 回顾性检出组中不对称肠壁增厚和息肉样肿块的出现频率高于前瞻性组(27% vs. 10.5% 和 26% vs. 17.1%)。
- 未检出肿瘤平均大小(2.9 cm)小于前瞻性组(6.0 cm)和回顾性组(4.9 cm)(P = 0.03)。
- 前瞻性组更多见结肠周围异常、区域/腹膜后淋巴结受累(P < 0.001)和远处转移(P = 0.01)。
- 未检出组静脉造影使用率最低(P = 0.003)。
诊断标准与关键数值
- 回顾性检出组检测信心低于前瞻性组(P = 0.03)。
- 升结肠肿瘤更易被回顾性检出而非前瞻性检出(OR 2.75,95% CI 1.07-7.08,P = 0.04)。
- 回顾性检出组中非腹痛指征更常见(P = 0.03)。
临床应用与阅片要点
- 无论CT检查指征如何,均应系统追踪结肠,尤其注意右半结肠。
- 关注息肉样肿块和不对称肠壁增厚,这些形态易被忽视。
- 考虑静脉造影以提高结直肠肿瘤检出率。
- 对较小肿瘤(约2.9 cm)保持警惕,避免漏诊。
局限性
- 回顾性研究设计,存在选择偏倚。
- 样本量有限(209例),单中心研究。
- 阅片者知晓肿瘤位置和大小,可能高估回顾性检出率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To report the detection rate of colorectal tumors with computed tomography (CT) performed within 1 year before diagnosis for indications other than colon abnormalities. Strategies to improve cancer detection are reported.
METHODS: Two board-certified, subspecialty-trained abdominal radiologists retrospectively reviewed patient health records and CT images with knowledge of tumor location/size. Patients were classified into 3 groups: prospective (colon abnormality suggesting neoplasm documented in radiologic report), retrospective (not documented in radiologic report but detected in our retrospective review of CT images), and undetected (neither prospectively nor retrospectively detected). Retrospective detection confidence and morphologic characteristics of each tumor were also recorded.
RESULTS: Of 209 included patients, 106 (50.7%) had prospectively detected tumors, 66 (31.6%) had retrospectively detected tumors, and 37 (17.7%) had undetected tumors. Asymmetric bowel wall thickening and polypoid masses were present more often in the retrospective group than in the prospective group (27% vs. 10.5% and 26% vs. 17.1%, respectively). Tumors in the ascending colon were more likely to be detected retrospectively than prospectively (odds ratio, 2.75; 95% CI 1.07-7.08; P = 0.04). Undetected tumors were smaller on average (2.9 cm) than prospective (6.0 cm) and retrospective (4.9 cm) tumors (P = 0.03). Detection confidence was lower for retrospectively detected tumors than for prospectively detected tumors (P = 0.03). Indications other than abdominal pain were most common for retrospectively detected tumors (P = 0.03). Use of intravenous contrast material was lowest in the undetected group (P = 0.003). The prospective group had more pericolonic abnormalities, regional/retroperitoneal lymph node involvement (P < 0.001), and distant metastases than did the retrospective group (P = 0.01).
CONCLUSION: Half of all colorectal tumors were not detected prospectively. Radiologists should perform meticulous colon tracking regardless of the indication for CT. The right colon merits additional examination. Polypoid and asymmetric morphologic characteristics were most often overlooked, but these characteristics can be learned to improve detection.
引用
- Johnson, Flicek, Mead-Harvey, et al. Strategies for improving colorectal cancer detection with routine computed tomography. Abdom Radiol (NY). 2023. PMID: 36961532. doi:10.1007/s00261-023-03884-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。